| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10011114 | HBV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS10011115 | HBV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS10033325 | HBV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS10034619 | HBV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS10043495 | HBV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS30007661 | HIV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS30007662 | HIV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS30015821 | HIV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS30015822 | HIV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
| TVIS30007663 | HIV | ENSG00000115306.17 | protein_coding | SPTBN1 | No | No | 6711 | B2ZZ89 Q01082 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SPTBN1 |
|---|---|
| DrugBank ID | DB01373 |
| Drug Name | Calcium |
| Target ID | BE0004593 |
| UniProt ID | Q01082 |
| Regulation Type | agonist |
| PubMed IDs | 1537825 |
| Citations | Wallis CJ, Wenegieme EF, Babitch JA: Characterization of calcium binding to brain spectrin. J Biol Chem. 1992 Mar 5;267(7):4333-7. |
| Groups | Nutraceutical |
| Direct Classification | |
| SMILES | [Ca] |
| Pathways | Lidocaine (Antiarrhythmic) Action Pathway; Reteplase Action Pathway; Arachidonic Acid Metabolism; Oxaprozin Action Pathway; Ardeparin Action Pathway; Heparin Action Pathway; Mefenamic Acid Action Pathway; Bromfenac Action Pathway; Riboflavin Metabolism; Alprenolol Action Pathway; Naproxen Action Pathway; Procainamide (Antiarrhythmic) Action Pathway; Sphingolipid Metabolism; Tranexamic Acid Action Pathway; Xanthine Dehydrogenase Deficiency (Xanthinuria); Meloxicam Action Pathway; Phenprocoumon Action Pathway; Streptokinase Action Pathway; Phenylketonuria; Gaucher Disease; Fc Epsilon Receptor I Signaling in Mast Cells; Ketorolac Action Pathway; Androgen and Estrogen Metabolism; Acetylsalicylic Acid Action Pathway; Bivalirudin Action Pathway; Aprotinin Action Pathway; Alpha Linolenic Acid and Linoleic Acid Metabolism; Malate-Aspartate Shuttle; Folate Metabolism; Adenylosuccinate Lyase Deficiency |
| PharmGKB | PA164712582 |
| ChEMBL |
